T Cell Function in Chronic Idiopathic Urticaria

Status Recruiting

Clinical Trial Summary

Chronic idiopathic urticaria (CIU) is a common form of chronic urticaria in which the cause is not detected after intensive clinical and laboratory investigation.In view of the current data, it was suggested that at least part of the patients with CIU have an autoimmune process.This study is designed to investigate the mechanisms involved in the regulation and activation of the immune cells in patients with CIU and corelate them with disease activity

Clinical Trial Description

n/a

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01425593
Study type	Observational
Source	Meir Medical Center
Contact
Status	Recruiting
Phase	N/A
Start date	March 2009
Completion date	December 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02435238` - AWARE - Chronic Urticaria	N/A
Not yet recruiting	`NCT05513079` - Positive Psychotherapy-Based Counseling (PPT)	N/A
Terminated	`NCT02047136` - Dietary Treatment for Chronic Urticaria	N/A
Completed	`NCT01803763` - Prospective Double-blind Placebo-controlled Study of the Effect of Xolair (Omalizumab) in Chronic Urticaria Patients	Phase 2/Phase 3
Terminated	`NCT01170949` - Efficacy and Safety of Miltefosine in Antihistamine Resistant Chronic Urticaria	Phase 2
Completed	`NCT00598611` - Effects of 5 mg vs. 20 mg Desloratadine on Skin Lesions in Patients With Chronic Urticaria (CU)	Phase 3
Completed	`NCT01610128` - Development of an Urticaria Control Test	N/A
Completed	`NCT02285049` - Cross-Cultural of the Validity, Reliability and Interpretability of Thai-version of Urticaria Control Test	N/A
Completed	`NCT02285023` - The Validity, Reliability and Interpretability of Thai-version of Chronic Urticaria Quality of Life Questionnaire
Completed	`NCT01715740` - Study of the Effects of Chinese Herbal Medicine on Chronic Urticaria	Phase 3
Completed	`NCT01960283` - Methotrexate in the Treatment of Chronic Idiopathic Urticaria	Phase 3
Completed	`NCT00481676` - Efficacy and Safety of Omalizumab in Adults (18-70 Years) With Moderate to Severe Chronic Urticaria	Phase 2
Completed	`NCT01713725` - Efficacy and Safety Study of Omalizumab (Xolair®) to Treat Chronic Urticaria	Phase 2
Completed	`NCT01250652` - Levocetirizine Plus Bed-Time Hydroxyzine in the Management of Corticodependent Chronic Urticaria Versus Levocetirizine Alone in High Doses	Phase 4
Completed	`NCT01111136` - Stress Intervention for Chronic Urticaria	N/A
Completed	`NCT00619801` - Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin	Phase 3
Completed	`NCT00737451` - Association of Thyroid Autoimmunity and Chronic Urticaria	N/A
Completed	`NCT00628108` - Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months	Phase 3
Completed	`NCT01284426` - Natural History of Chronic Urticaria	N/A
Withdrawn	`NCT01073852` - Hydroxychloroquine Efficacy in Chronic Urticaria	N/A